Paper8093890
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A and 3 others. J Exp Med, 1993. Cited by 378 papers, by iCite.
Cite this record
ConductScience Library. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. Papers, record 8093890. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8093890
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| HIV Antigens | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Herpesvirus 4, Human | Major topic |
| Immunity, Cellular | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Adult | |
| Antigens, Viral | |
| CD4-Positive T-Lymphocytes | |
| Female | |
| Gene Products, env | |
| Gene Products, gag | |
| Gene Products, pol | |
| Humans | |
| Leukocyte Count | |
| Male | |
| Time Factors |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6267157 | Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. | J Exp Med | 1981 | https://conductscience.org/library/papers/6267157 | PubMed |
| 2 | 6602294 | Cytotoxic T-cell immunity to influenza. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6602294 | PubMed |
| 3 | 2431484 | CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. | Science | 1986 | https://conductscience.org/library/papers/2431484 | PubMed |
| 4 | 3041033 | CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. | J Virol | 1987 | https://conductscience.org/library/papers/3041033 | PubMed |
| 5 | 2831276 | Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines. | J Immunol | 1988 | https://conductscience.org/library/papers/2831276 | PubMed |
| 6 | 2832181 | Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. | Eur J Immunol | 1988 | https://conductscience.org/library/papers/2832181 | PubMed |
| 7 | 2842692 | Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. | Nature | 1988 | https://conductscience.org/library/papers/2842692 | PubMed |
| 8 | 2844952 | Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. | J Exp Med | 1988 | https://conductscience.org/library/papers/2844952 | PubMed |
| 9 | 2460873 | Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2460873 | PubMed |
| 10 | 2463308 | Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. | J Immunol | 1989 | https://conductscience.org/library/papers/2463308 | PubMed |
| 11 | 2522999 | Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. | J Virol | 1989 | https://conductscience.org/library/papers/2522999 | PubMed |
| 12 | 2550139 | Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. | Cell | 1989 | https://conductscience.org/library/papers/2550139 | PubMed |
| 13 | 2161883 | Automation of limiting dilution cytotoxicity assays. | J Immunol Methods | 1990 | https://conductscience.org/library/papers/2161883 | PubMed |
| 14 | 2145214 | Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. | Immunology | 1990 | https://conductscience.org/library/papers/2145214 | PubMed |
| 15 | 2147200 | Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis. | J Immunol | 1990 | https://conductscience.org/library/papers/2147200 | PubMed |
| 16 | 2083233 | High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. | Int Immunol | 1990 | https://conductscience.org/library/papers/2083233 | PubMed |
| 17 | 1652311 | Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. | Blood | 1991 | https://conductscience.org/library/papers/1652311 | PubMed |
| 18 | 1718319 | Cytotoxic T-cell recognition of HIV proteins and peptides. | AIDS | 1991 | https://conductscience.org/library/papers/1718319 | PubMed |
| 19 | 1744586 | Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. | J Exp Med | 1991 | https://conductscience.org/library/papers/1744586 | PubMed |
| 20 | 1370302 | Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. | J Clin Invest | 1992 | https://conductscience.org/library/papers/1370302 | PubMed |
Cited by122
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 378 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34406857 | Redondovirus Diversity and Evolution on Global, Individual, and Molecular Scales. | J Virol | 2021 | https://conductscience.org/library/papers/34406857 | PubMed |
| 29467764 | Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine. | Front Immunol | 2018 | https://conductscience.org/library/papers/29467764 | PubMed |
| 27113787 | Human CD8(+) T cells transduced with an additional receptor bispecific for both Mycobacterium tuberculosis and HIV-1 recognize both epitopes. | J Cell Mol Med | 2016 | https://conductscience.org/library/papers/27113787 | PubMed |
| 26083409 | T-Cell Subsets Predict Mortality in Malnourished Zambian Adults Initiating Antiretroviral Therapy. | PLoS One | 2015 | https://conductscience.org/library/papers/26083409 | PubMed |
| 23809163 | Specific gut commensal flora locally alters T cell tuning to endogenous ligands. | Immunity | 2013 | https://conductscience.org/library/papers/23809163 | PubMed |
| 23544708 | Functional proteome of macrophage carried nanoformulated antiretroviral therapy demonstrates enhanced particle carrying capacity. | J Proteome Res | 2013 | https://conductscience.org/library/papers/23544708 | PubMed |
| 20500844 | Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy. | BMC Infect Dis | 2010 | https://conductscience.org/library/papers/20500844 | PubMed |
| 19091857 | Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivo. | J Virol | 2009 | https://conductscience.org/library/papers/19091857 | PubMed |
| 18360285 | Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. | J Acquir Immune Defic Syndr | 2008 | https://conductscience.org/library/papers/18360285 | PubMed |
| 17100767 | An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa. | Clin Exp Immunol | 2006 | https://conductscience.org/library/papers/17100767 | PubMed |
| 16630020 | Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy. | Immunology | 2006 | https://conductscience.org/library/papers/16630020 | PubMed |
| 15742158 | Not all tetramer binding CD8+ T cells can produce cytokines and chemokines involved in the effector functions of virus-specific CD8+ T lymphocytes in HIV-1 infected children. | J Clin Immunol | 2005 | https://conductscience.org/library/papers/15742158 | PubMed |
| 15719067 | Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15719067 | PubMed |
| 15583014 | CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. | J Exp Med | 2004 | https://conductscience.org/library/papers/15583014 | PubMed |
| 15367623 | Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection. | J Virol | 2004 | https://conductscience.org/library/papers/15367623 | PubMed |
| 15367590 | Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag. | J Virol | 2004 | https://conductscience.org/library/papers/15367590 | PubMed |
| 15024179 | Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection. | J Clin Immunol | 2004 | https://conductscience.org/library/papers/15024179 | PubMed |
| 15024178 | Immune reconstitution and viral stimulation are required to restore HIV-specific CD8 T cell responses following advanced infection. | J Clin Immunol | 2004 | https://conductscience.org/library/papers/15024178 | PubMed |
| 14983032 | Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/14983032 | PubMed |
| 12974761 | Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness. | Clin Exp Immunol | 2003 | https://conductscience.org/library/papers/12974761 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8093890
GET https://conductscience.org/api/papers/v1/8093890/references?page=2